Ibersuizas said to have sold MD Anderson
Ibersuizas is thought to have finalised its sale of MD Anderson España, the Spanish subsidiary of the MD Anderson Cancer Centre of Houston, according to reports.
The private equity firm has been in negotiations for months about an exit, as the business is believed to be making a loss and requires an urgent capital increase. Investment bank Confivendis was hired to advise the transaction.
Ibersuizas first acquired a 45% stake in the business in early 2000 in order to support its growth plans within the Iberian Peninsula.
In 2003 it teamed up with the now-extinct Inveralia to acquire up to 85% of the company's shares for €3.2m, while the rest of the equity remained in the hands of the parent company and the centre's medical team.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








